45

Hepatitis C virus (HCV) infections are a significant global health concern, representing the primary cause of chronic hepatitis and liver disease. While current treatments can be effective, they are costly and often come with adverse side effects, highlighting the pressing need for new therapeutic strategies and a preventive vaccine. A deeper understanding of the interactions between HCV and host cells is critical for elucidating disease progression and may reveal novel cellular targets for antiviral drug development. This review examines the relationship between HCV and the host cell's innate immune system, detailingthe cellular pathways activated in response to infection and the strategies employed by the virus to evade these intracellular defenses

  • Read count 45
  • Date of publication 08-03-2025
  • Main LanguageIngliz
  • Pages 295-304
English

Hepatitis C virus (HCV) infections are a significant global health concern, representing the primary cause of chronic hepatitis and liver disease. While current treatments can be effective, they are costly and often come with adverse side effects, highlighting the pressing need for new therapeutic strategies and a preventive vaccine. A deeper understanding of the interactions between HCV and host cells is critical for elucidating disease progression and may reveal novel cellular targets for antiviral drug development. This review examines the relationship between HCV and the host cell's innate immune system, detailingthe cellular pathways activated in response to infection and the strategies employed by the virus to evade these intracellular defenses

№ Author name position Name of organisation
1 Bazarova G.R. ! Alfraganus “university’
№ Name of reference
1 1.Spearman, C.W.; Dusheiko, G.M.; Hellard, M.; Sonderup, M. Hepatitis C.Lancet2019,394, 1451–1466. [Google Scholar] [CrossRef]2.World Health Organization—WHO.Global Hepatitis Report 2017; World Health Organization: Geneva, Switzerland, 2017. [Google Scholar]3.World Health Organization Hepatitis C. Available online:https://www.who.int/news-room/fact-sheets/detail/hepatitis-c(accessed on 29 February 2020).4.Gottwein, J.M.; Bukh, J. Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems.Adv. Virus Res.2008,71, 51–133. [Google Scholar] [CrossRef] [PubMed]5.Borgia, S.M.; Hedskog, C.; Parhy, B.; Hyland, R.H.; Stamm, L.M.; Brainard, D.M.; Subramanian, M.G.; McHutchison, J.G.; Mo, H.; Svarovskaia, E.; et al. Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes.J. Infect. Dis.2018,218, 1722–1729. [Google Scholar] [CrossRef] [PubMed] [Green Version]6.Thomas, E.; Feld, J.J.; Li, Q.; Hu, Z.; Fried, M.W.; Liang, T.J. Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models.Hepatology2011,53, 32–41. [Google Scholar] [CrossRef] [PubMed]7.Spengler, U. Direct antiviral agents (DAAs)—A new age in the treatment of hepatitis C virus infection.Pharmacol. Ther.2018,183, 118–126. [Google Scholar] [CrossRef]8.Levrero, M. Viral hepatitis and liver cancer: The case of hepatitis C.Oncogene2006,25, 3834–3847. [Google Scholar] [CrossRef] [Green Version]9.Medzhitov, R.; Janeway, C.A. Innate Immunity: The Virtues of a Nonclonal System of Recognition.Cell1997,91, 295–298. [Google Scholar] [CrossRef] [Green Version]10.Janeway, C.A.; Medzhitov, R. Innate Immune Recognition.Annu. Rev. Immunol.2002,20, 197–216. [Google Scholar] [CrossRef] [Green Version]11.Gao, B.; Jeong, W.-I.; Tian, Z. Liver: An organ with predominant innate immunity.Hepatology2008,47, 729–736. [Google Scholar] [CrossRef]12.Thompson, M.R.; Kaminski, J.J.; Kurt-Jones, E.A.; Fitzgerald, K.A. Pattern recognition receptors and the innate immune response to viral infection.Viruses2011,3, 920–940. [Google Scholar] [CrossRef] [Green Version]13.Moradpour, D.; Penin, F.; Rice, C.M. Replication of hepatitis C virus.Nat. Rev. Microbiol.2007,5, 453–463. [Google Scholar] [CrossRef] [PubMed]14.Ito, M.; Masumi, A.; Mochida, K.; Kukihara, H.; Moriishi, K.; Matsuura, Y.; Yamaguchi, K.; Mizuochi, T. Peripheral B Cells May Serve as a Reservoir for Persistent Hepatitis C Virus Infection.J. Innate Immun.2010,2, 607–617. [Google Scholar] [CrossRef] [PubMed]15.Egger, D.; Wölk, B.; Gosert, R.; Bianchi, L.; Blum, H.E.; Moradpour, D.; Bienz, K.; Bianchi, L. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex.J. Virol.2002,76, 5974–5984. [Google Scholar] [CrossRef] [PubMed] [Green Version]16.Gosert, R.; Egger, D.; Lohmann, V.; Bartenschlager, R.; Blum, H.E.; Bienz, K.; Moradpour, D. Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells HarboringSubgenomic Replicons.J. Virol.2003,77, 5487–5492. [Google Scholar] [CrossRef] [Green Version]17.Bartenschlager, R.; Lohmann, V. Replication of hepatitis C virus.J. Gen. Virol.2000,81, 1631–1648. [Google Scholar] [CrossRef]18.Enomoto, N.; Sato, C. Hepatitis C virusquasispeciespopulations during chronic hepatitis C infection.Trends Microbiol.1995,3, 445–447. [Google Scholar] [CrossRef]19.Tsukiyama-Kohara, K.; Kohara, M. Hepatitis C Virus: ViralQuasispeciesand Genotypes.Int. J. Mol. Sci.2018,19, 23. [Google Scholar] [CrossRef] [Green Version]20.Bartenschlager, R.; Penin, F.; Lohmann, V.; André, P. Assembly of infectious hepatitis C virus particles.Trends Microbiol.2011,19, 95–103. [Google Scholar] [CrossRef]21.Boulant, S.; Douglas, M.W.; Moody, L.; Budkowska, A.; Targett-Adams, P.; McLauchlan, J. Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule-and dynein-dependent manner.Traffic2008,9, 1268–1282. [Google Scholar] [CrossRef]22.Suzuki, T. Assembly of hepatitis C virus particles.Microbiol. Immunol.2011,55, 12–18. [Google Scholar] [CrossRef]23.Tews, B.A.; Popescu, C.-I.; Dubuisson, J. Last stop before exit—Hepatitis C assembly and releaseas antiviral drug targets.Viruses2010,2, 1782–1803. [Google Scholar] [CrossRef] [PubMed]
Waiting